Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS

• Autor(a) principal: Setúbal,Sérgio
• Data de Publicação: 2003
• Outros Autores: Jorge-Pereira,Maria Cristina, Sant'Anna,Anadayr Leite Martins de, Oliveira,Solange Artimos de, Bazin,Anna Ricordi, Nascimento,Jussara Pereira do
• Tipo de documento: Relatório
• Idioma: eng
• Título da fonte: Revista da Sociedade Brasileira de Medicina Tropical
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822003000200014
• topic: Erythema infectiosum; Sickle cell anemia; Parvovirus; Pure red cell aplasia; AIDS

Human parvovirus B19 replicates in erythrocyte precursors. Usually, there are no apparent hematological manifestations. However, in individuals with high erythrocyte turnover, as in patients with sickle-cell disease and in the fetus, the infection may lead to severe transient aplasia and hydrops fetalis, respectively. In AIDS patients, persistent infection may result in chronic anemia. By contrast, in HIV-positive patients without AIDS the infection evolves as a mild exanthematous disease. Two clinical descriptions exemplify these forms of presentation. In the first, an AIDS patient presented with bone marrow failure that responded to immunoglobulin. In the second, an HIV-positive patient without AIDS had a morbilliform rash, and needed no treatment. Knowing that an AIDS patient has chronic B19 anemia lessens concern about drug anemia; protects the patient from invasive diagnostic maneuvers; and prevents the patient from disseminating the infection. In AIDS patients with pure red cell aplasia, a search for parvovirus B19 DNA in the serum or in the bone marrow is warranted.